AYTU

NASDAQ · Pharmaceuticals

Aytu Biopharma Inc

Penny Stocks Pharmaceutical Stocks Healthcare Stocks

$2.16

+0.04 (+1.89%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +323.6% upside

Low Target $5.34

Average Target $9.15

High Target $10.98

Current Price $2.16

Current
$2.16

Target
$9.15

$5.34 $9.15 avg $10.98

Scenario Analysis

Bear Case

$5.34

147.2%

Low target

Base Case

$9.15

+323.6%

Avg target

Bull Case

$10.98

+408.3%

High target

Risk/Reward

2.8x

Favorable

Price in Context

52-Week High

$3.07

-29.5% from high

52-Week Low

$1.65

+30.9% from low

Target vs 52W High

$9.15

+198.5% vs high

Next Earnings Report

Sep 22, 2026 · After Market Close

Today

EPS Est: $-0.33

Earnings in today. Analyst targets may shift significantly after the report.

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+14.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+11.2%
MRK Merck & Co. Inc.	Buy	36	72%	$159.27	+6.5%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+22.2%
BMY Bristol-Myers Squibb Co	Hold	35	43%	$174.50	+178.7%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-38.0%
ZTS Zoetis Inc	Hold	24	50%	$209.87	+194.2%